In vitro evaluation of a novel multiwalled carbon nanotube/nanohydroxyapatite/polycaprolactone composite for bone tissue engineering. Issue 4 (21st February 2019)

• Record Type: Journal Article
• Authors: Yang, Huixiao; Li, Jieqing; Liao, Qiong; Guo, Hua; Chen, Huishan; Zhu, Yuting; Cai, Meijuan; Lv, Huling
• Is Part Of: Journal of materials research. Volume 34:Issue 4(2019)
• Page Start: 532
• Page End: 544
• Publication Date: 2019-02-21
• Subjects: nanostructure, -- combinatorial synthesis, -- polymer; Materials -- Research -- Periodicals; 620.1105
• DOI: 10.1557/jmr.2018.484
• Languages: English
• ISSNs: 0884-2914

Abstract

Abstract: Abstract : In this study, a three-phased multiwalled scaffold, composed of carbon nanotube (mwCNT), nanocrystalline hydroxyapatite (nHA), and polycaprolactone (PCL), was fabricated by the solvent evaporation technique. The structure character, mechanical properties, and degradation activity in simulated body fluid (SBF), along with osteoproductive ability in human osteosarcoma cell MG63, were investigated thoroughly. Results showed that the three phases in mwCNT/nHA/PCL composite presented excellent miscibility and stronger interfacial force when the weight content was 1/15/84 (wt%). Simultaneously, the composite had smaller porosity and slower degradation rate, and there was massive crystallized hydroxyapatite formed on the surface after being soaked in SBF. With regard to bioactivity, MG63s on this scaffolds presented good proliferation performance and differentiated into the osteogenic lineage by expressing high levels of ALP. It was concluded that mwCNTs/nHA/PCL composite scaffolds might be beneficial for bone tissue engineering at a relatively low concentration of mwCNTs and nHA.